FDA Moves to Reevaluate Several Peptides American Med Spa Association When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype